X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
curative resection (4273) 4273
humans (3880) 3880
surgery (2791) 2791
male (2721) 2721
female (2678) 2678
index medicus (2516) 2516
middle aged (2433) 2433
aged (2294) 2294
oncology (2250) 2250
prognosis (1815) 1815
cancer (1701) 1701
survival (1619) 1619
adult (1576) 1576
carcinoma (1305) 1305
retrospective studies (1145) 1145
gastroenterology & hepatology (1142) 1142
chemotherapy (1129) 1129
aged, 80 and over (1064) 1064
neoplasm staging (1062) 1062
treatment outcome (1048) 1048
recurrence (956) 956
survival rate (940) 940
adenocarcinoma (875) 875
medicine & public health (825) 825
colorectal cancer (803) 803
analysis (723) 723
survival analysis (696) 696
care and treatment (691) 691
colorectal-cancer (688) 688
follow-up studies (672) 672
metastasis (656) 656
risk factors (656) 656
disease-free survival (595) 595
chemotherapy, adjuvant (587) 587
pancreatic cancer (576) 576
adenocarcinoma - surgery (561) 561
combined modality therapy (555) 555
gastric cancer (539) 539
multivariate analysis (520) 520
research (515) 515
stomach neoplasms - pathology (514) 514
stomach neoplasms - surgery (512) 512
radiotherapy (504) 504
pancreatic neoplasms - surgery (483) 483
lymphatic metastasis (480) 480
hepatocellular carcinoma (472) 472
adjuvant chemotherapy (444) 444
liver neoplasms - surgery (441) 441
colorectal neoplasms - pathology (432) 432
time factors (432) 432
health aspects (423) 423
stomach cancer (412) 412
surgical oncology (412) 412
tumors (409) 409
adenocarcinoma - pathology (399) 399
colorectal neoplasms - surgery (392) 392
pancreatic neoplasms - pathology (382) 382
mortality (381) 381
rectal-cancer (373) 373
therapy (372) 372
adenocarcinoma - mortality (371) 371
antineoplastic combined chemotherapy protocols - therapeutic use (371) 371
hepatectomy (370) 370
kaplan-meier estimate (370) 370
gastroenterology (357) 357
pancreatic neoplasms - mortality (357) 357
pancreaticoduodenectomy (357) 357
long-term survival (353) 353
proportional hazards models (349) 349
follow-up (348) 348
medical prognosis (348) 348
prognostic-factors (345) 345
rectal neoplasms - surgery (342) 342
stomach neoplasms - mortality (341) 341
gastrectomy (332) 332
prospective studies (331) 331
abridged index medicus (328) 328
local recurrence (328) 328
neoplasm invasiveness (328) 328
chemoradiotherapy (326) 326
neoplasm recurrence, local (320) 320
risk-factors (320) 320
neoplasm recurrence, local - pathology (311) 311
patients (311) 311
carcinoma, hepatocellular - surgery (309) 309
colon-cancer (309) 309
ductal adenocarcinoma (306) 306
liver cancer (305) 305
curative surgery (302) 302
radiotherapy, adjuvant (297) 297
neoadjuvant therapy (289) 289
randomized controlled-trial (287) 287
liver neoplasms - mortality (286) 286
liver neoplasms - pathology (286) 286
adjuvant therapy (283) 283
resection (283) 283
patient outcomes (281) 281
phase-iii trial (281) 281
radiation-therapy (281) 281
hepatic resection (279) 279
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4895) 4895
German (138) 138
French (79) 79
Japanese (33) 33
Spanish (32) 32
Korean (25) 25
Italian (9) 9
Lithuanian (2) 2
Chinese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 09/2010, Volume 304, Issue 10, pp. 1073 - 1081
Journal Article
Journal Article
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 03/2019, Volume 119, Issue 4, pp. 455 - 463
Hepatocellular carcinoma (HCC) has a recurrence rate of up to 70% in 5 years after resection, detrimentally lowering survival. The role of adjuvant therapy... 
adjuvant hepatic artery infusion therapy (HAIT) | hepatocellular carcinoma (HCC) | resection | SURVIVAL | SURGERY | CHEMOEMBOLIZATION | CURATIVE RESECTION | IODINE-131-LABELED LIPIODOL | CANCER | CHEMOTHERAPY | 5-FLUOROURACIL | ONCOLOGY | CIRRHOSIS | RECURRENCE | RADIOFREQUENCY ABLATION | Surgery | Analysis | Hepatoma | Intravenous therapy | Liver cancer | Systematic review | Cancer surgery
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2017, Volume 35, Issue 5, pp. 515 - 515
Purpose To compare overall survival between patients who received neoadjuvant therapy (NAT) followed by resection and those who received upfront resection... 
ADJUVANT CHEMOTHERAPY | SURVIVAL | MANAGEMENT | SINGLE | ONCOLOGY | ADENOCARCINOMA | CHEMORADIATION | CURATIVE RESECTION | OUTCOMES | FLUOROURACIL | GEMCITABINE
Journal Article
Journal Article
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2016, Volume 114, Issue 7, pp. 895 - 899
Journal Article
JAMA Surgery, ISSN 2168-6254, 03/2019, Volume 154, Issue 3, pp. 209 - 217
IMPORTANCE Late recurrence (more than 2 years) after liver resection for hepatocellular carcinoma (HCC) is generally considered as a multicentric tumor or a de... 
LATE INTRAHEPATIC RECURRENCE | UNITED-STATES | SURGERY | MANAGEMENT | CURATIVE RESECTION | HCC | CANCER STATISTICS | COHORT | SELECTION | MILAN CRITERIA | RADIOFREQUENCY ABLATION
Journal Article
Liver International, ISSN 1478-3223, 02/2016, Volume 36, Issue 2, pp. 293 - 301
Journal Article